Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$302.09 - $373.65 $22.4 Million - $27.7 Million
74,000 Added 4111.11%
75,800 $28.3 Million
Q1 2024

May 13, 2024

SELL
$337.92 - $470.1 $6.59 Million - $9.17 Million
-19,500 Reduced 91.55%
1,800 $624,000
Q4 2023

Feb 14, 2024

BUY
$451.42 - $524.21 $8.98 Million - $10.4 Million
19,900 Added 1421.43%
21,300 $9.75 Million
Q3 2023

Nov 14, 2023

BUY
$424.29 - $501.07 $594,006 - $701,498
1,400 New
1,400 $681,000
Q3 2021

Nov 15, 2021

BUY
$389.15 - $471.22 $116,745 - $141,366
300 Added 17.65%
2,000 $778,000
Q2 2021

Aug 16, 2021

BUY
$407.15 - $469.97 $692,155 - $798,949
1,700 New
1,700 $753,000
Q3 2019

Nov 14, 2019

SELL
$255.67 - $304.87 $20.5 Million - $24.4 Million
-80,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$232.89 - $276.48 $18.6 Million - $22.1 Million
80,000 New
80,000 $21.6 Million

Others Institutions Holding HUM

About HUMANA INC


  • Ticker HUM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 126,554,000
  • Market Cap $35.7B
  • Description
  • Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services t...
More about HUM
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.